Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished May 23, 2026 6:31 AM ・ Updated Jun 13, 2026 11:52 PM ・ 2 min read ・ Source: PR Times
KangPei Biotech approved its 2025 financial statements, loss compensation plan, board re-election, and employee stock incentive plans at the AGM on May 22, 2026.
On May 22, 2026, KangPei Biotech held its annual general meeting and passed several key resolutions: approval of the 2025 loss compensation plan and financial statements, completion of the full re-election of the board of directors, amendments to the employee restricted stock issuance plan, issuance of 2026 restricted employee shares, and the removal of non-compete restrictions for new directors.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.